⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,141.09
+0.01%
Brent
$109.22
−0.54%
BTC
$82,103.95
+0.11%
ETH
$2,412.84
+0.23%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,141.09
+0.01%
Brent
$109.22
−0.54%
BTC
$82,103.95
+0.11%
ETH
$2,412.84
+0.23%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NYSE
› NVS
N
Novartis AG
NYSE:NVS
Healthcare
$150.20
−0.28%
At close
At close · Tue 20 Oct · ≈
AED 551.61
· Market cap
$277.86B
· Next earnings
Tue 27 Oct
· Extended
$150.22
+0.01%
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
NVS news
Headlines tagged to this company
SE
Notable healthcare headlines for the week: Pfizer, Sanofi, and Novartis in focus
Seeking Alpha · 15 d ago
SE
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
Seeking Alpha · 17 d ago
SE
Merck succeeds in mid-stage trial for skin disease drug
Seeking Alpha · 19 d ago
SE
Catalyst Watch: Jobs report, Trump AI talks, and ticking fee time for Paramount
seekingalpha · 24 d ago
SE
Lantheus gains approval of Bravnesta, generic competitor to Lutathera
seekingalpha · 27 d ago
SE
Cue Biopharma plummets on phase 2 data for chronic spontaneous urticaria asset
seekingalpha · 28 d ago
SE
Novartis scraps ALS therapy after mid-stage trial setback
seekingalpha · 33 d ago
SE
Novartis' Lutathera now facing generic competition from Cirium's Bexlutry
seekingalpha · 34 d ago
SE
Trending stocks this week as markets end lower amid inflation, yield jitters
seekingalpha · 36 d ago
SE
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
seekingalpha · 36 d ago
SE
Notable analyst calls this week: Lockheed Martin, Meta and Intel among top picks
seekingalpha · 37 d ago
SE
Olema drops after hours on AstraZeneca Etcamah data
seekingalpha · 38 d ago
SE
Chip stocks lead Nasdaq's weekly gains; Amgen plunges after trial setback
seekingalpha · 38 d ago
GU
Novartis's $30 Billion Deal Spree Triggers a Boardroom Reckoning
gurufocus · 38 d ago
GU
Novartis Rebounds as $30 Billion Wipeout Draws Board Challenge
gurufocus · 39 d ago
SE
Novartis facing board change threat from shareholder following trial failures
seekingalpha · 39 d ago
SE
Novartis extends selloff as Deutsche Bank cuts on twin drug trial setbacks
seekingalpha · 40 d ago
SE
Astra, Roche win new Outperform ratings as RBC initiates EU pharma coverage
seekingalpha · 40 d ago
SE
Dyne extends slide as J.P. Morgan downgrades on Novartis setback
seekingalpha · 40 d ago
GU
Novartis Crashes 13.5% After $12 Billion Deal's Lead Drug Fails
gurufocus · 41 d ago
More news →
Novartis AG · News · TradingHolo